CalettiMGBalestracciADi PintoD. Pre- and post-treatment urinary tract findings in children with nephrogenic diabetes insipidus. Pediatr Nephrol. 2014;29:487-490.
KnoersNMonnensLA. Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus. J Pediatr. 1990;117:499-502.
6.
WescheDDeenPMKnoersNV. Congenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr Nephrol. 2012;27:2183-2204.
7.
BockenhauerDBichetDG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol. 2015;11:576-588.
8.
HoekstraJAvan LieburgAFMonnensLAHulstijn-DirkmaatGMKnoersVV. Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet. 1996;61:81-88.
9.
KirchlechnerVKollerDSeidlRWaldhauserF. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride. Arch Dis Child. 1999;80:548-552.
10.
UyekiTMBarryFLRosenthalSMMathiasRS. Successful treatment with hydrochlorothiazide and amiloride in an infant with congenital nephrogenic diabetes insipidus. Pediatr Nephrol. 1993;7:554-556.
11.
KnoersN. Nephrogenic diabetes insipidus. 2000 February 12 [Updated 2012 Jun 14]. In: PagonRAAdamMPArdingerHH, eds. GeneReviews [Internet]. Seattle, WA: University of Washington; 1993-2016.